William MacNee
Overview
Explore the profile of William MacNee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
12377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vila M, Agusti A, Vestbo J, Celli B, Cosio B, Silverman E, et al.
ERJ Open Res
. 2025 Feb;
11(1).
PMID: 40008176
Background: The ECLIPSE study was a large, international, prospective, controlled, observational study that included COPD patients (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades 2-4), as well as smoking...
2.
Donaldson K, Wallace W, MacNee W, Henry C, Seaton A
J R Coll Physicians Edinb
. 2022 Sep;
52(1):65-72.
PMID: 36146963
From the identification of a specific lung disease caused by coal dust exposure in miners in 1831 until the demonstration of the association of that exposure to risk of emphysema...
3.
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, et al.
Trials
. 2022 Apr;
23(1):307.
PMID: 35422024
Background: Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity, mortality and healthcare costs. Beta blockers are well-established drugs widely used to treat cardiovascular conditions. Observational studies consistently report...
4.
Fermont J, Fisk M, Bolton C, MacNee W, Cockcroft J, Fuld J, et al.
BMJ Open
. 2020 Dec;
10(12):e038360.
PMID: 33372069
Objectives: Although cardiovascular disease (CVD) is a common comorbidity associated with chronic obstructive pulmonary disease (COPD), it is unknown how to improve prediction of cardiovascular (CV) risk in individuals with...
5.
Celli B, Locantore N, Yates J, Bakke P, Calverley P, Crim C, et al.
Eur Respir J
. 2020 Dec;
57(3).
PMID: 33303557
Rationale: There are no validated measures of disease activity in COPD. Since "active" disease is expected to have worse outcomes ( mortality), we explored potential markers of disease activity in...
6.
Chen D, Ballout S, Chen L, Cheriyan J, Choudhury G, Denis-Bacelar A, et al.
J Nucl Med
. 2020 Sep;
61(12):1701-1707.
PMID: 32948678
PET with F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases...
7.
Fermont J, Mohan D, Fisk M, Bolton C, MacNee W, Cockcroft J, et al.
Age Ageing
. 2020 Sep;
50(3):795-801.
PMID: 32894757
Rationale: chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and common in older adults. The BODE Index is the most recognised mortality risk score in COPD but...
8.
Fermont J, Bolton C, Fisk M, Mohan D, MacNee W, Cockcroft J, et al.
PLoS One
. 2020 Feb;
15(2):e0228940.
PMID: 32040531
In chronic obstructive pulmonary disease (COPD), acute exacerbation of COPD requiring hospital admission is associated with mortality and healthcare costs. The ERICA study assessed multiple clinical measures in people with...
9.
Mohan D, Benson V, Allinder M, Galwey N, Bolton C, Cockcroft J, et al.
Chronic Obstr Pulm Dis
. 2020 Jan;
7(1):13-25.
PMID: 31999899
Objective: To identify phenotypic factors associated with the Short Physical Performance Battery (SPPB) and its individual sub-tests: standing balance, 4‑meter gait speed (4mGS) and 5-repetition sit-to-stand (5STS). Methods: The Evaluation...
10.